Aurora Cannabis Inc. (TSX: ACB)

Market Cap	337.11M
Revenue (ttm)	270.36M
Net Income (ttm)	-72.36M
Shares Out	54.55M
EPS (ttm)	-1.70
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	391,468
Open	6.33
Previous Close	6.32
Day's Range	n/a
52-Week Range	3.84 - 15.50
Beta	2.59
Analysts	n/a
Price Target	7.74 (+25.24%)
Earnings Date	Aug 8, 2024

About Aurora Cannabis

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 1,073
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ACB

Financial Performance

In 2023, ACB's revenue was 270.28 million, an increase of 16.71% compared to the previous year's 231.58 million. Losses were -69.33 million, -73.72% less than in 2022.